ATE135711T1 - Antihypertensive derivate - Google Patents

Antihypertensive derivate

Info

Publication number
ATE135711T1
ATE135711T1 AT85111454T AT85111454T ATE135711T1 AT E135711 T1 ATE135711 T1 AT E135711T1 AT 85111454 T AT85111454 T AT 85111454T AT 85111454 T AT85111454 T AT 85111454T AT E135711 T1 ATE135711 T1 AT E135711T1
Authority
AT
Austria
Prior art keywords
antihypertensive
derivatives
substituents
chem
compounds
Prior art date
Application number
AT85111454T
Other languages
English (en)
Inventor
Edward S Neiss
John T Suh
John R Regan
Jerry W Skiles
Jeffrey N Barton
Paul Menard
James J Mencel
Original Assignee
Rhone Poulenc Rorer Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/649,797 external-priority patent/US4746676A/en
Priority claimed from US06/752,695 external-priority patent/US4749698A/en
Application filed by Rhone Poulenc Rorer Pharma filed Critical Rhone Poulenc Rorer Pharma
Application granted granted Critical
Publication of ATE135711T1 publication Critical patent/ATE135711T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06191Dipeptides containing heteroatoms different from O, S, or N
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06078Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT85111454T 1984-09-12 1985-09-10 Antihypertensive derivate ATE135711T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/649,797 US4746676A (en) 1984-09-12 1984-09-12 Carboxyalkyl dipeptide compounds
US06/752,695 US4749698A (en) 1985-07-08 1985-07-08 Antihypertensive derivatives

Publications (1)

Publication Number Publication Date
ATE135711T1 true ATE135711T1 (de) 1996-04-15

Family

ID=27095707

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85111454T ATE135711T1 (de) 1984-09-12 1985-09-10 Antihypertensive derivate

Country Status (13)

Country Link
EP (1) EP0175266B1 (de)
KR (1) KR860002464A (de)
AT (1) ATE135711T1 (de)
AU (1) AU578489B2 (de)
CA (1) CA1288893C (de)
DE (1) DE3588094T2 (de)
DK (1) DK412985A (de)
ES (1) ES8609364A1 (de)
FI (1) FI89716C (de)
IL (1) IL76345A (de)
IN (1) IN164615B (de)
NO (1) NO169442C (de)
NZ (1) NZ213432A (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5629345A (en) * 1993-07-23 1997-05-13 Vide Pharmaceuticals Methods and compositions for ATP-sensitive K+ channel inhibition for lowering intraocular pressure
US5965620A (en) * 1993-07-23 1999-10-12 Vide Pharmaceuticals Methods and compositions for ATP-sensitive K+ channel inhibition for lowering intraocular pressure
WO1995034577A1 (en) * 1994-06-16 1995-12-21 Smithkline Beecham Corporation Template directed cyclization
ATE324876T1 (de) 1999-10-14 2006-06-15 Curis Inc VERMITTLER VON ßHEDGEHOGß ÜBERMITTELNDEN BAHNEN, DAZUGEHÖRIGE ZUSAMMENETZUNGEN UND VERWENDUNGEN
DE50015940D1 (de) 2000-09-21 2010-07-29 Abb Schweiz Ag Konfiguration eines Leitsystems einer elektrischen Schaltanlage
WO2007078990A2 (en) * 2005-12-23 2007-07-12 Zealand Pharma A/S Modified lysine-mimetic compounds
EP2074087A2 (de) 2006-12-21 2009-07-01 Wyeth Synthese von pyrrolidinverbindungen
CN110709096B (zh) 2017-05-05 2023-10-31 泽兰德制药公司 细胞间隙连接通讯调节剂及其在糖尿病性眼病治疗中的应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5683483A (en) * 1979-12-13 1981-07-08 Santen Pharmaceut Co Ltd Thiazolidine compound
US4350704A (en) * 1980-10-06 1982-09-21 Warner-Lambert Company Substituted acyl derivatives of octahydro-1H-indole-2-carboxylic acids
EP0048159A3 (de) * 1980-09-17 1982-05-12 University Of Miami Carboxyalkyl-Peptide und Thioäther und Äther von Peptiden als antihypertensive Mittel
US4462943A (en) * 1980-11-24 1984-07-31 E. R. Squibb & Sons, Inc. Carboxyalkyl amino acid derivatives of various substituted prolines
FR2501399B1 (fr) * 1981-03-03 1987-06-19 France Etat Dispositif d'affichage de messages graphiques transmis par des systemes de videotex
EP0080822A1 (de) * 1981-11-27 1983-06-08 Beecham Group Plc Antihypertensive auf Prolin basierende Peptide
EP0088350B1 (de) * 1982-03-08 1985-02-20 Schering Corporation Carboxyalkyl-Dipeptiden, Verfahren zu deren Herstellung und deren pharmazeutische Zusammensetzungen
ZA832762B (en) * 1982-04-30 1983-12-28 Squibb & Sons Inc Substituted 4-phenoxy prolines
IL69136A0 (en) * 1982-07-19 1983-10-31 Squibb & Sons Inc Substituted peptide compounds
US4623729A (en) * 1982-07-22 1986-11-18 E. R. Squibb & Sons, Inc. Acylalkylaminocarbonyl substituted amino and imino acid compounds
US4499079A (en) * 1982-11-18 1985-02-12 E. R. Squibb & Sons, Inc. Carboxy and substituted carboxy alkanoyl and cycloalkanoyl peptides
FI841052A (fi) * 1983-03-16 1984-09-17 Usv Pharma Corp Foereningar foer behandling av blodtryckssjukdomar.
EP0127124A3 (de) * 1983-05-23 1987-04-08 Usv Pharmaceutical Corporation Verbindungen zur Behandlung von hohem Blutdruck

Also Published As

Publication number Publication date
CA1288893C (en) 1991-09-10
NO853551L (no) 1986-03-13
KR860002464A (ko) 1986-04-26
DK412985D0 (da) 1985-09-11
NO169442C (no) 1992-06-24
DK412985A (da) 1986-03-13
DE3588094D1 (de) 1996-04-25
IN164615B (de) 1989-04-22
FI89716C (fi) 1993-11-10
FI853494L (fi) 1986-03-13
EP0175266A2 (de) 1986-03-26
AU4733185A (en) 1986-03-20
FI89716B (fi) 1993-07-30
NZ213432A (en) 1988-11-29
ES546866A0 (es) 1986-07-16
AU578489B2 (en) 1988-10-27
FI853494A0 (fi) 1985-09-12
EP0175266A3 (en) 1988-08-03
ES8609364A1 (es) 1986-07-16
IL76345A0 (en) 1986-01-31
EP0175266B1 (de) 1996-03-20
NO169442B (no) 1992-03-16
IL76345A (en) 1988-12-30
DE3588094T2 (de) 1996-08-22

Similar Documents

Publication Publication Date Title
ATE70833T1 (de) Piperazinyl-heterocyclische derivate.
DE68913022T2 (de) Heterozyklische Derivate.
DK0386675T3 (da) Xanthinderivater
DE58904761D1 (de) Chirale derivate des 1,2 -difluorbenzols.
ATE75743T1 (de) Hydrazinderivate und ihre verwendung.
FI863833A (fi) Imidazolinyl-derivat, foerfaranden foer deras framstaellning och dessa foereningar innehaollande medel med herbicid verkan.
ATE135711T1 (de) Antihypertensive derivate
DK521685A (da) Spergualin-derivater og anvendelse deraf til fremstilling af laegemidler med immunosuppressiv virkning
DE68912007T2 (de) Antiparasitäre Derivate.
ES8704875A1 (es) Procedimiento de producir compuestos para tratar la hiper- tension
DE58903514D1 (de) Derivate der 2,3-difluorbenzoesaeure.
ATE102624T1 (de) Makrolide derivate.
ATE54151T1 (de) Erythromycylamin-derivate.
ES8602021A1 (es) Procedimiento de preparar compuestos espirociclicos antihi- pertensivos
DE3771597D1 (de) Pyridazinon derivate und ihre salze.
DE3686632T2 (de) Antibiotische derivate, ihre herstellung und verwendung.
ATE23151T1 (de) Derivate des 1,4-dihydropyridins.
ATE54912T1 (de) Mevalonolactonaehnliche imidazole und derivate.
ATE101395T1 (de) Heterozyklische derivate.
SU1432991A1 (ru) 4-Метил-5-(4-метилфениламино)-1,2,3-триазол, обладающий противовоспалительной активностью
ATE80163T1 (de) Antibiotische derivate, ihre herstellung und verwendung.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties